Log in to save to my catalogue

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9821091

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study

About this item

Full title

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study

Publisher

Switzerland: MDPI AG

Journal title

Journal of clinical medicine, 2022-12, Vol.12 (1), p.25

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Approximately 60% of acromegaly patients are not adequately controlled by first-generation somatostatin receptor ligands. This multicenter retrospective study aimed to identify the most relevant biomarkers specific for the Italian acromegaly population. Resistant patients were enrolled consecutively based on time of neurosurgery, while responders w...

Alternative Titles

Full title

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9821091

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9821091

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm12010025

How to access this item